Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 14;12(4):e0175794.
doi: 10.1371/journal.pone.0175794. eCollection 2017.

Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality

Affiliations

Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality

Te-Wei Ho et al. PLoS One. .

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide. There is evidence to support a connection between COPD and diabetes mellitus (DM), another common medical disorder. However, additional research is required to improve our knowledge of these relationships and their possible implications. In this study, we investigated the impact of DM on patient outcomes through the clinical course of COPD.

Methods: We conducted a cohort study in patients from the Taiwan Longitudinal Health Insurance Database between 2000 and 2013. Patients with COPD were identified and assessed for pre-existing and incident DM. A Cox proportional hazards model was built to identify factors associated with incident DM and to explore the prognostic effects of DM on COPD patients. A propensity score method was used to match COPD patients with incident DM to controls without incident DM.

Results: Pre-existing DM was present in 332 (16%) of 2015 COPD patients who had a significantly higher hazard ratio (HR) [1.244, 95% confidence interval (CI) 1.010-1.532] for mortality than that of the COPD patients without pre-existing DM. During the 10-year follow-up period, 304 (19%) of 1568 COPD patients developed incident DM; comorbid hypertension (HR, 1.810; 95% CI, 1.363-2.403), cerebrovascular disease (HR, 1.517; 95% CI, 1.146-2.008) and coronary artery disease (HR, 1.408; 95% CI 1.089-1.820) were significant factors associated with incident DM. Survival was worse for the COPD patients with incident DM than for the matched controls without incident DM (Log-rank, p = 0.027).

Conclusions: DM, either pre-existing or incident, was associated with worse outcomes in COPD patients. _targeted surveillance and management of DM may be important in clinical care of the COPD population.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study flow diagram.
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.
Fig 2
Fig 2. Adjusted Kaplan–Meier curves for survival in all COPD patients with and without pre-existing DM (n = 2015).
aAdjusted for age, gender, comorbidities (hypertension, dyslipidemia, cerebrovascular disease, heart failure, and coronary artery disease) and concomitant medications (ACEI/ARB, calcium channel blocker, and statin). ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.
Fig 3
Fig 3. Cumulative hazard rate of incident DM in COPD patients according to comorbidity status (n = 1568).
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.
Fig 4
Fig 4. Kaplan-Meier curves for survival in COPD patients with incident DM and matched controls.
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.

Similar articles

Cited by

References

    1. Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. 10.1016/S0140-6736(15)60692-4 - DOI - PMC - PubMed
    1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. http://goldcopd.org.
    1. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):367–70; discussion 71–2. 10.1513/pats.200504-026SR - DOI - PubMed
    1. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–85. 10.1183/09031936.00128008 - DOI - PubMed
    1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40. 10.1016/S0140-6736(11)60679-X - DOI - PubMed

MeSH terms

Grants and funding

This study was supported in part by a grant from the Ministry of Science and Technology, Taiwan (MOST 105-2221-E-002-155-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  NODES
INTERN 2
twitter 2